Merus N.V. CS (MRUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRUS | AZN | AMGN | GILD | VRTX |
| Company | Merus N.V. CS | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 44.29 | 68.85 | 279.91 | 105.95 | 488.27 |
| High | 45.90 | 69.27 | 283.60 | 106.64 | 498.41 |
| Low | 40.72 | 68.36 | 276.42 | 99.32 | 484.96 |
| Last | 41.83 | 68.51 | 277.90 | 106.38 | 492.42 |
| Change | -1.38 | +0.64 | -0.50 | +0.87 | +1.95 |
| % Change | -3.19% | +0.94% | -0.18% | +0.82% | +0.40% |
| Volume | 1,738,400 | 5,674,000 | 2,679,600 | 8,178,700 | 1,247,300 |
| 20-Day Average Volume | 946,290 | 6,791,230 | 3,230,285 | 9,313,936 | 1,695,490 |
| Previous Close | 43.21 | 67.87 | 278.40 | 105.51 | 490.47 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 41.49 | 69.12 | 292.72 | 107.19 | 486.39 |
| 20-Day Raw Stochastic | 64.19% | 50.28% | 22.06% | 51.98% | 73.19% |
| 20-Day Relative Strength | 47.82% | 44.75% | 40.39% | 49.39% | 52.84% |
| Weighted Alpha | -20.95 | -10.95 | -3.70 | +59.15 | +20.29 |
| Today's Opinion | 72% Sell | 72% Sell | 56% Sell | 40% Buy | 56% Buy |
| Previous Opinion | 56% Sell | 72% Sell | 56% Sell | 40% Buy | 72% Buy |
| Last Month's Opinion | 8% Buy | 16% Buy | 40% Buy | 80% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.22% since 04/15/25 | +0.94% since 04/15/25 | -5.89% since 04/15/25 | +0.66% since 04/15/25 | -1.61% since 04/15/25 |
| Low | 40.72 on 04/23/25 | 66.59 on 04/21/25 | 268.50 on 04/17/25 | 99.32 on 04/23/25 | 472.90 on 04/21/25 |
| High | 45.90 on 04/23/25 | 69.27 on 04/23/25 | 294.75 on 04/16/25 | 106.64 on 04/23/25 | 502.22 on 04/16/25 |
| 1-Month | |||||
| %Chg | -11.45% since 03/21/25 | -8.57% since 03/21/25 | -12.07% since 03/21/25 | -0.65% since 03/21/25 | -2.14% since 03/21/25 |
| Low | 33.19 on 04/09/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 97.32 on 04/09/25 | 448.14 on 04/07/25 |
| High | 49.80 on 03/24/25 | 75.70 on 04/03/25 | 317.58 on 03/24/25 | 114.75 on 04/03/25 | 513.97 on 03/24/25 |
| 3-Month | |||||
| %Chg | +1.75% since 01/23/25 | -0.13% since 01/23/25 | +0.01% since 01/23/25 | +14.49% since 01/23/25 | +11.98% since 01/23/25 |
| Low | 33.19 on 04/09/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 92.26 on 01/24/25 | 430.81 on 01/29/25 |
| High | 49.88 on 03/13/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -20.03% since 10/23/24 | -10.97% since 10/23/24 | -11.75% since 10/23/24 | +21.95% since 10/23/24 | +4.76% since 10/23/24 |
| Low | 33.19 on 04/09/25 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 86.08 on 11/19/24 | 377.85 on 12/19/24 |
| High | 55.39 on 11/07/24 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,985,379 | 210,481,632 | 149,682,048 | 131,377,152 | 125,947,800 |
| Shares Outstanding, K | 69,090 | 3,101,247 | 537,651 | 1,245,163 | 256,790 |
| Annual Sales | 36,130,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -215,330,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 9,140,000 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -30,920,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | 1.02 | 0.49 | 0.59 | 0.32 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.41 on 02/27/25 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 05/14/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.28 | 13.81 | 22.63 | 0.00 |